COCRYSTAL PHARMA, INC. Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)
COCRYSTAL PHARMA, INC. (COCP) reported Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) of -$38.00 thousand for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-09.
Discontinued › Income Statement › Other Income
us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss · last filed 2016-11-09
- COCRYSTAL PHARMA, INC. fair value, asset, recurring basis, still held, unrealized gain (loss) for the quarter ending 2016-09-30 was -$38.00K, a 101.25% decline year-over-year.
- COCRYSTAL PHARMA, INC. fair value, asset, recurring basis, still held, unrealized gain (loss) for the quarter ending 2016-06-30 was $938.00K, a 67.51% decline year-over-year.
- COCRYSTAL PHARMA, INC. fair value, asset, recurring basis, still held, unrealized gain (loss) for the quarter ending 2015-09-30 was $3.04M.
- COCRYSTAL PHARMA, INC. fair value, asset, recurring basis, still held, unrealized gain (loss) for the quarter ending 2015-06-30 was $2.89M.
| Period end | Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) 3 month | Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) 6 month | Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) 9 month |
|---|---|---|---|
| 2016-09-30 | -$38.00K 10-Q · filed 2016-11-09 | $900.00K derived: sum of 2 quarters · filed 2016-11-09 | $2.17M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $938.00K 10-Q · filed 2016-08-09 | $2.21M 10-Q · filed 2016-08-09 | |
| 2015-09-30 | $3.04M 10-Q · filed 2016-11-09 | $5.92M derived: sum of 2 quarters · filed 2016-11-09 | -$8.49M 10-Q · filed 2016-11-09 |
| 2015-06-30 | $2.89M 10-Q · filed 2016-08-09 | -$11.53M 10-Q · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |